Experienced in Teratocarcinosarcoma

Dr. Shih J. Wei

Radiation Oncology
Community Physicians Of Indiana Inc
7229 Clearvista Dr, 
Indianapolis, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Teratocarcinosarcoma
Community Physicians Of Indiana Inc
7229 Clearvista Dr, 
Indianapolis, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Shih Wei is a Radiation Oncologist in Indianapolis, Indiana. Dr. Wei is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Posterior Fossa Tumor. Dr. Wei is currently accepting new patients.

His clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in IN
Hospital Affiliations
Community Howard Regional Health Inc.
Community Hospital North
Riverview Health
Community Hospital East
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

COMMUNITY PHYSICIANS OF INDIANA INC
7229 Clearvista Dr, Indianapolis, IN 46256

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Enrollment Status: Recruiting
Publish Date: September 19, 2025
Intervention Type: Drug, Other, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
View 3 Less Clinical Trials
Similar Doctors
Advanced in Teratocarcinosarcoma
Dr. Mark P. Langer
Radiation Oncology
Advanced in Teratocarcinosarcoma
Dr. Mark P. Langer
Radiation Oncology

University Radiation Oncology Associates, Inc.

10212 Lantern Rd, 
Fishers, IN 
 (3.0 miles away)
317-678-2700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Langer is a Radiation Oncologist in Fishers, Indiana. Dr. Langer is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Bone Tumor, and Adult Soft Tissue Sarcoma. Dr. Langer is currently accepting new patients.

Experienced in Teratocarcinosarcoma
Dr. Sandeep R. Bhave
Radiation Oncology
Experienced in Teratocarcinosarcoma
Dr. Sandeep R. Bhave
Radiation Oncology

Cancer Care Group PC

Indianapolis, IN 
 (13.6 miles away)
317-715-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sandeep Bhave is a Radiation Oncologist in Indianapolis, Indiana. Dr. Bhave is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Melanoma, and Laryngeal Cancer. Dr. Bhave is currently accepting new patients.

Experienced in Teratocarcinosarcoma
Dr. Christopher A. Leagre
Radiation Oncology
Experienced in Teratocarcinosarcoma
Dr. Christopher A. Leagre
Radiation Oncology

Cancer Care Group PC

Indianapolis, IN 
 (13.6 miles away)
317-715-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Leagre is a Radiation Oncologist in Indianapolis, Indiana. Dr. Leagre is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Radiation Induced Meningioma, Meningioma, Intraductal Papilloma, and Astrocytoma. Dr. Leagre is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wei's expertise for a condition
ConditionClose
    View All 29 Advanced Conditions
    View All 46 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile